Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist (Q26749189)

Journal of Diabetes Investigation

31 July 2019

physiological phenomenon

1 reference

20 August 2019

1 reference

12 September 2019

1 reference

10 October 2019

1 reference

12 October 2019

1 reference

17 November 2019

1 reference

15 December 2019

Kenichi Katsurada

1

0 references

Toshihiko Yada

series ordinal

2

0 references

language of work or name

English

0 references

publication date

April 2016

0 references

1 April 2016

7 references

31 July 2019

20 August 2019

12 September 2019

10 October 2019

12 October 2019

17 November 2019

15 December 2019

8 references

31 July 2019

20 August 2019

12 September 2019

10 October 2019

12 October 2019

17 November 2019

15 December 2019

7 Suppl 1

0 references

page(s)

64-9

0 references

copyright license

Creative Commons Attribution-NonCommercial

7 references

31 July 2019

20 August 2019

12 September 2019

10 October 2019

12 October 2019

17 November 2019

15 December 2019

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Cardiovascular actions of incretin-based therapies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstem

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Preproglucagon neurons project widely to autonomic control areas in the mouse brain.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Cholecystokinin increases cytosolic calcium in a subpopulation of cultured vagal afferent neurons

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Peripheral oxytocin activates vagal afferent neurons to suppress feeding in normal and leptin-resistant mice: a route for ameliorating hyperphagia and obesity.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like Peptide 1 neurons

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

31 May 2018

1 reference

Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.

21 January 2018

1 reference

Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.

21 January 2018

1 reference

Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons

21 January 2018

1 reference

Characterization of CCK(A) receptor affinity states and Ca(2+) signal transduction in vagal nodose ganglia

21 January 2018

1 reference

Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons.

21 January 2018

1 reference

Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels

21 January 2018

1 reference

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways

21 January 2018

1 reference

Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei.

21 January 2018

1 reference

Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons.

21 January 2018

1 reference

Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons

21 January 2018

1 reference

GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.

21 January 2018

1 reference

Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin

21 January 2018

1 reference

Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model

21 January 2018

1 reference

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

21 January 2018

1 reference

Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4854507

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

28 November 2018

1 reference

12 December 2020

Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat

1 reference

12 December 2020

A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia

1 reference

12 December 2020

Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats

1 reference

12 December 2020

Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor

1 reference

12 December 2020

Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites

1 reference

12 December 2020

GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats

1 reference

12 December 2020

Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia

1 reference

12 December 2020